87
Views
2
CrossRef citations to date
0
Altmetric
Articles

Hepatoprotectant potential of sodium alginate coated catechin nanoparticles (SACC-NPs) in rat model

, , , , , , & show all
Pages 1334-1342 | Received 25 Sep 2019, Accepted 10 Mar 2020, Published online: 05 May 2020
 

Abstract

Hepatoprotective effects of many antioxidants have been attributed with its uncertain bioavailability at the target cell. Research in drug delivery today is to design a nano-carrier system to deliver drugs at target cell with desired dose and duration. In this study, sodium alginate coated catechin nanoparticle (SACC-NP) carrier system was evaluated for its in vivo anti-oxidant potential in rat model revealed improvement in hematological, biochemical parameters and oxidative stress markers on day 28th of SACC-NPs treated group of rats (Gr. V). Significant improvement in healing pattern of liver along with regenerative changes during histopathology studies was observed in the rats of Gr. V. Results of gross pathology and histopathology with the liver of rats receiving SACC-NPs has been re-confirmed again by May-Grunwald Giemsa staining which recorded prominent regenerative changes in liver. Modified scoring pattern also re-ascertained regenerative changes in the liver tissue of the rats receiving SACC-NPs.

Acknowledgement

The authors are thankful to Indian Council of Agricultural Research, Ministry of Agriculture and farmer welfare, New Delhi, India for providing financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.